1. Home
  2. DAKT vs CSTL Comparison

DAKT vs CSTL Comparison

Compare DAKT & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DAKT
  • CSTL
  • Stock Information
  • Founded
  • DAKT 1968
  • CSTL 2007
  • Country
  • DAKT United States
  • CSTL United States
  • Employees
  • DAKT N/A
  • CSTL N/A
  • Industry
  • DAKT Office Equipment/Supplies/Services
  • CSTL Medical Specialities
  • Sector
  • DAKT Industrials
  • CSTL Health Care
  • Exchange
  • DAKT Nasdaq
  • CSTL Nasdaq
  • Market Cap
  • DAKT 710.0M
  • CSTL 697.9M
  • IPO Year
  • DAKT 1994
  • CSTL 2019
  • Fundamental
  • Price
  • DAKT $22.92
  • CSTL $22.89
  • Analyst Decision
  • DAKT Strong Buy
  • CSTL Strong Buy
  • Analyst Count
  • DAKT 1
  • CSTL 6
  • Target Price
  • DAKT $26.00
  • CSTL $37.67
  • AVG Volume (30 Days)
  • DAKT 524.1K
  • CSTL 449.5K
  • Earning Date
  • DAKT 09-10-2025
  • CSTL 11-03-2025
  • Dividend Yield
  • DAKT N/A
  • CSTL N/A
  • EPS Growth
  • DAKT 9.66
  • CSTL N/A
  • EPS
  • DAKT 0.23
  • CSTL N/A
  • Revenue
  • DAKT $749,361,000.00
  • CSTL $346,269,000.00
  • Revenue This Year
  • DAKT $10.38
  • CSTL N/A
  • Revenue Next Year
  • DAKT $6.41
  • CSTL N/A
  • P/E Ratio
  • DAKT $97.24
  • CSTL N/A
  • Revenue Growth
  • DAKT N/A
  • CSTL 20.40
  • 52 Week Low
  • DAKT $10.24
  • CSTL $14.59
  • 52 Week High
  • DAKT $24.38
  • CSTL $35.84
  • Technical
  • Relative Strength Index (RSI)
  • DAKT 74.19
  • CSTL 57.06
  • Support Level
  • DAKT $22.47
  • CSTL $21.28
  • Resistance Level
  • DAKT $24.38
  • CSTL $24.74
  • Average True Range (ATR)
  • DAKT 0.89
  • CSTL 1.06
  • MACD
  • DAKT 0.53
  • CSTL -0.28
  • Stochastic Oscillator
  • DAKT 80.04
  • CSTL 42.77

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: